Bibliographic Details
| Title: |
A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy. |
| Authors: |
Harding FA; Genencor International, 925 Page Mill Road, Palo Alto, California 94304, USA., Liu AD, Stickler M, Razo OJ, Chin R, Faravashi N, Viola W, Graycar T, Yeung VP, Aehle W, Meijer D, Wong S, Rashid MH, Valdes AM, Schellenberger V |
| Source: |
Molecular cancer therapeutics [Mol Cancer Ther] 2005 Nov; Vol. 4 (11), pp. 1791-800. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
